List view / Grid view
29 June 2016 | By Victoria White, Digital Content Producer
A study suggests efavirenz might be an effective therapy for stimulating cholesterol turnover from the brain and slowing or preventing Alzheimer's disease...
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have described a strategy to stabilise an important HIV structure and potentially create HIV lookalikes for large-scale vaccine production...
11 April 2016 | By Victoria White, Digital Content Producer
Mymetics’ HIV vaccine candidate generated significant protection in groups of twelve female monkeys against repeated AIDS virus exposures...
6 April 2016 | By Victoria White
Scientists have described the first-ever immature antibody found in a powerful class of immune molecules effective against HIV. TSRI biologist Jiang Zhu called the antibody a “teenager” and said it gives scientists a unique view of the steps needed to prompt the immune system to effectively target HIV...
3 March 2016 | By Victoria White
According to the research, a drug for a disease that affects twice as many people will generate twice the revenue. But vaccine revenue depends on finer details about how the risk is distributed in the population...
25 February 2016 | By Victoria White
Data from the preclinical study support continued investigation of GS-9620 as part of an HIV eradication strategy…
14 January 2016 | By Victoria White
The Human Vaccines Project is a research programme designed to accelerate the development of vaccines by decoding the human immune system...
11 January 2016 | By Victoria White
The proceeds will support the development of Aelix’s lead candidate HTI immunogen as a therapeutic vaccine against HIV infection up to the completion of a Phase 2 proof-of-concept efficacy trial in HIV-infected individuals...
19 November 2015 | By Victoria White
A new study suggests that gamma interferon, which is an FDA-approved drug, may have potential as an antiviral therapy to prevent Ebola infection when given either before or after exposure to the virus...
18 November 2015 | By Victoria White
When studying prototype antibodies that target a specific weak spot on HIV, the researchers noted two of the antibodies had an unusual feature that could prove important in vaccine design...
10 November 2015 | By Victoria White
Sanofi Pasteur's experimental vaccine is a novel synthetic vaccine generated from key genetic sequences of many flu viruses...
3 November 2015 | By Kate Douetil
The European AIDS Vaccine Initiative (EAVI2020) is a new EUR 23 million project, financed by the European Commission...
28 September 2015 | By Victoria White
H7N9 candidate vaccines have failed to elicit a strong immune response necessary to protect from infection. A study has revealed that it may be due to immune camouflage...
25 September 2015 | By Victoria White
When eCD4-lg was tested in animal models, the results were so powerful and effective that they suggested the compound’s potential to serve the role of an alternative HIV/AIDS vaccine...
17 September 2015 | By Vicky White
By identifying ERManI as the target that slows the spread of HIV-1, researchers have revealed a target in which future therapies can be developed...
